59
Participants
Start Date
November 19, 2018
Primary Completion Date
October 9, 2025
Study Completion Date
October 9, 2025
Ibrutinib
Ibrutinib capsule, tablet, or suspension administered orally once daily
St. Anna Kinderspital, Vienna
Sydney Children's Hospital, Randwick
Cancer Center for Children. The Children's Hospital at Westmead, Westmead
The Royal Children's Hospital, Parkville
Queensland Children's Hospital, South Brisbane
Memorial Sloan Kettering Cancer Center, New York
S.C. Farmacia Pediatrica - Presidio Ospedaliero Infantile Regina Margherita, Turin
Charite-Universitaetsmedizin Berlin, Berlin
The Children's Hospital of Philadelphia, Philadelphia
Children's National Medical Center, Washington D.C.
Fondazione MBBM-Clinica Pediatrica, Monza
Johns Hopkins University, Baltimore
U.O.C. Ematologia Oncoematologia Pediatrica, Pavia
Hospital Infantil Universitario Nino Jesus, Madrid
Hospital Universitario Universitario La Paz, Madrid
Johns Hopkins All Children's Hospital, St. Petersburg
CHU Nantes - Hopital Enfant Adolescent, Nantes
Cincinnati Children's Hospital Medical Center, Cincinnati
Medical College of Wisconsin, Milwaukee
University of Minnesota Masonic Children's Hospital, Minneapolis
Ann & Robert H Lurie Children's Hospital of Chicago, Chicago
Washington University, St Louis
Hôpital Robert-Debré Ap-Hp, Paris
Children's Hospital, Aurora
Primary Children's Hospital, Salt Lake City
City of Hope, Duarte
Rady Children's Hospital, San Diego
University of California, San Francisco
Oregon Health and Science University, Portland
Fred Hutchinson Cancer Research Center, Seattle
"Federal State Budgetary Institution Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology", Moscow
"Federal State Budgetary Educational Institution of Higher Professional Education LP.Pavlov First Saint Petersburg State Medical", Saint Petersburg
Schneider Children's Medical Center in Israel, Petah Tikva
The Edmond and Lily Safra Children's Hospital, Ramat Gan
Hadassah Medical Centre, Jerusalem
Dana-Farber Cancer Institute, Boston
Hackensack University Medical Center, Hackensack
St. Jude Children's Research Hospital, Memphis
children's and Women's Health Centre of British Columbia, Vancouver
CHU Sainte-Justine, Montreal
Dipartimento di Onco-Ematologia e Terapia Cellulare e Genica, Roma
Princess Maxima Center, Utrecht
Seoul National University Hospital, Seoul
Asan Medical Center, Seoul
Samsung Medical Center, Seoul
Seoul Saint Mary's Hospital, Seoul
Hospital Universitario Vall d'Hebron, Barcelona
Safari Day Care, Great Ormond Street Hospital, London
Lead Sponsor
Janssen Research & Development, LLC
INDUSTRY
Pharmacyclics LLC.
INDUSTRY